Brought to you by 
Genzyme Corp division Genzyme Molecular withdraws its IPO
13 Jul 1999
Executive Summary
Genzyme Corp. division Genzyme Molecular Oncology (GMO) has filed for an initial public offering of 3mm shares of common stock. The offering price of the stock will be between $9-$11 per share.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
-
Drug Discovery Tools
- Molecular Diversity
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
- Spin-Off
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genzyme Corp division Genzyme Molecular withdraws its IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice